Skip to main content
Clinical Trials/JPRN-UMIN000009398
JPRN-UMIN000009398
Completed
未知

To evaluate treatment efficacy after switching medication in reflux esophagitis patients who have parsistent gastro- esophageal reflux symptoms despite standard PPI therapy - To evaluate treatment efficacy after switching medication in PPI refractory GERD patients

The Jikei University School of Medicine0 sites15 target enrollmentDecember 1, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Gastroesophageal reflux disease
Sponsor
The Jikei University School of Medicine
Enrollment
15
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2012
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\)The patient has warning signs such as vomiting and gastrointestinal hemorrhage. (2\)The patient needs to continue any drug that might interact with esomeprazole. (3\)The patient previously had or currently has any of the following diseases. Zollinger\-Ellison syndrome Esophageal stenosis Esophageal achalasia Cerebrovascular disorders such as cerebral hemorrhage and cerebral infarction (4\)The patient has any serious hepatic, renal, or cardiac disease that makes participation in the study difficult in the opinion of the investigator. (5\)The patient has a confirmed or suspected malignant lesion. (6\)The patient is a pregnant, nursing, or possibly pregnant woman. (7\)The patient is otherwise ineligible for participation in the study in the investigator's or subinvestigator's opinion.

Outcomes

Primary Outcomes

Not specified

Similar Trials